KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023)

Historic Change in Inventory for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q2 2023 value amounting to -$694000.0.

  • Ginkgo Bioworks Holdings' Change in Inventory fell 1663.87% to -$694000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was -$7.5 million, marking a year-over-year decrease of 23837.73%. This contributed to the annual value of -$164000.0 for FY2022, which is 12619.81% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Change in Inventory of -$694000.0 as of Q2 2023, which was down 1663.87% from -$1.9 million recorded in Q1 2023.
  • Ginkgo Bioworks Holdings' 5-year Change in Inventory high stood at $5.3 million for Q1 2022, and its period low was -$2.7 million during Q4 2022.
  • Over the past 4 years, Ginkgo Bioworks Holdings' median Change in Inventory value was -$595000.0 (recorded in 2022), while the average stood at -$15454.5.
  • Within the past 5 years, the most significant YoY rise in Ginkgo Bioworks Holdings' Change in Inventory was 68340.68% (2022), while the steepest drop was 227678.57% (2022).
  • Quarter analysis of 4 years shows Ginkgo Bioworks Holdings' Change in Inventory stood at $1.9 million in 2020, then plummeted by 105.84% to -$112000.0 in 2021, then plummeted by 2276.79% to -$2.7 million in 2022, then surged by 73.93% to -$694000.0 in 2023.
  • Its Change in Inventory was -$694000.0 in Q2 2023, compared to -$1.9 million in Q1 2023 and -$2.7 million in Q4 2022.